CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 44 enrolled
Drug / intervention
Minocycline HCldrug
Likely dose
Minocycline HCl 1mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00662532
NCT00662532Phase 3Completed
CompareCT.gov

Multi-Center Phase 3 Trial of Minocycline HCl 1mg Microspheres for the Use in Subjects With Peri-Implantitis

OraPharma·interventional·Posted Apr 21, 2008·Updated Dec 12, 2011

In Brief

A Phase 3 clinical trial evaluating Minocycline HCl for Periodontitis. Completed, enrolled 44 participants across 4 sites.

Detailed Summary

This study is for people at least 21 years old who have signs of problems, like swollen gums and shrinking bones, by dental implants.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPeriodontitis
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedApr 21, 2008
Enrollment StartApr 1, 2008
Primary CompletionApr 1, 2009
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 18.2 years ago

Interventions

Minocycline HCldrug

1mg microspheres for professional subgingival administration into periodontal pockets two times throughout the duration of the trial